iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS)

CUSIP: 46565G104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
10,000
Total 13F shares
24,955,604
Share change
+24,955,604
Total reported value
$614,284,488
Price per share
$24.67
Number of holders
54
Value change
+$614,284,486
Number of buys
54

Quarterly Holders Quick Answers

What is CUSIP 46565G104?
CUSIP 46565G104 identifies ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ITOS - iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q3 2020

As of 30 Sep 2020, iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,955,604 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, MPM ASSET MANAGEMENT LLC, MPM ONCOLOGY IMPACT MANAGEMENT LP, Artal Group S.A., JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, ALLIANCEBERNSTEIN L.P., and BlackRock Inc.. This page lists 54 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q3 2020 holders
54
Holder diff
53
Investor Q3 2025 Shares Q3 2020 Shares Share Diff Share Chg % Q3 2025 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .